11 October 2021: EditorialDinah V. Parums *
Med Sci Monit 2021; 27:e935005
ABSTRACT: Recent studies on the pathogenesis and clinical spectrum of human disease following infection with the new human pathogen, SARS-CoV-2, have identified the varied presentations and sequelae of COVID-19. Acute ‘cytokine storm’ in severe COVID-19 results in multiorgan damage due to vascular hyperpermeability, edema, and hypercoagulation. The long-term consequences of infection from SARS-CoV-2 include long COVID. or post-COVID syndrome, and multisystem inflammatory syndrome in children (MIS-C). Several case reports of multisystem inflammatory syndrome in adults (MIS-A) have shown the presentation at more than four weeks after initial infection with SARS-CoV-2 in adults more than 21 years of age. In September 2021, a published systematic review of the literature identified 221 patients with MIS-A, representing the most comprehensive clinical study to date. MIS-A occurs in the post-acute COVID-19 period. The pathogenesis may involve a dysregulated antibody-mediated immune response, similar to MIS-C. Therefore, patients with MIS-A may respond to supportive therapies that control hyperinflammation. This Editorial aims to describe MIS-A and discuss COVID-19 as a spectrum of hyperinflammatory disease in terms of severity, extent, duration, and patient age.
Keywords: Editorial, Multisystem Inflammatory Disease, Adults, MIS-A, SARS-CoV-2, COVID-19
There remain many questions regarding the presentation, pathogenesis, and outcome of MIS-A. Until more is known about the clinical presentation of MIS-A and its diagnosis, future cases are likely to be unrecognized. Because cases of MIS-A occur in the post-acute COVID-19 period, the pathogenesis may involve a dysregulated antibody-mediated immune response, similar to MIS-C. Therefore, patients with MIS-A may respond to supportive therapies that control hyperinflammation. Although the incidence of MIS-A is unknown, as with MIS-C in children, MIS-A is likely to be an uncommon complication of SARS-CoV-2 infection in adults.
1. Parasher A: COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment: Postgrad Med J, 2021; 97(1147); 312-20
2. Parasher A: COVID research: a year of scientific milestones: Nature, 2021; 2021
3. Siemieniuk RA, Bartoszko JJ, Ge L: Drug treatments for COVID-19: living systematic review and network meta-analysis: BMJ, 2020; 370; m2980
4. Malone B, Campbell EA: Molnupiravir: Coding for catastrophe: Nat Struct Mol Biol, 2021; 28(9); 706-8
5. Li X, Zhong X, Wang Y: Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis: PLoS One, 2021; 16(5); e0250602
6. Li X, Zhong X, Wang Y: COVID-19 treatment guidelines: Clinical spectrum of SARS-CoV-2 infection, 2021
7. Weatherhead JE, Clark E, Vogel TP: Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum: J Clin Invest, 2020; 130(12); 6194-97
8. Choudhary S, Sharma K, Silakari O: The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options: Microb Pathog, 2021; 150; 104673
9. Webb BJ, Peltan ID, Jensen P: Clinical criteria for COVID-19-associated hyperinflammatory syndrome: A cohort study: Lancet Rheumatol, 2020; 2(12); e754-63
10. Parums DV: Editorial: Long COVID, or post-COVID syndrome, and the global impact on health care: Med Sci Monit, 2021; 27; e933446
11. Parums DV: Editorial: COVID-19 and multisystem inflammatory syndrome in children (MIS-C): Med Sci Monit, 2021; 27; e933369
12. Morris SB, Schwartz NG, Patel P: Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection – United Kingdom and United States, March–August 2020: MMWR Morb Mortal Wkly Rep, 2020; 69(40); 1450-56
13. Davogustto GE, Clark DE, Hardison E: Characteristics associated with multisystem inflammatory syndrome among adults with SARS-CoV-2 infection: JAMA Netw Open, 2021; 4(5); e2110323
14. Dufort EM, Koumans EH, Chow EJ: Multisystem inflammatory syndrome in children in New York State: N Engl J Med, 2020; 383(4); 347-58
15. Patel P, DeCuir J, Abrams J: Clinical characteristics of multisystem inflammatory syndrome in adults: A systematic review: JAMA Netw Open, 2021; 4(9); e2126456
16. Chow EJ: The multisystem inflammatory syndrome in adults with SARS-CoV-2 infection – another piece of an expanding puzzle: JAMA Netw Open, 2021; 4(5); e2110344
17. Hanson KE, Caliendo AM, Arias CA:: Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: Serologic testing
11 January 2022 : Clinical ResearchA Remote Questionnaire-Based Study to Compare Alcohol Use in 1030 Final-Year High School Students in Split-...
Med Sci Monit In Press; DOI: 10.12659/MSM.935567
08 November 2021 : Database AnalysisVirtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Cor...
Med Sci Monit In Press; DOI: 10.12659/MSM.934102
31 December 2021 : Clinical ResearchA Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus...
Med Sci Monit 2021; 27:e935075
14 Jan 2022 : Database AnalysisIdentification of Key Genes Associated with Brain Metastasis from Breast Cancer: A Bioinformatics Analysis
Med Sci Monit In Press; DOI: 10.12659/MSM.935071
13 Jan 2022 : Review articleA Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hyperc...
Med Sci Monit In Press; DOI: 10.12659/MSM.935821
13 Jan 2022 : Clinical ResearchEffect of Cerebral Microbleeds on Cognitive Function and Quality of Life in Parkinson Disease
Med Sci Monit In Press; DOI: 10.12659/MSM.935026
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996
05 Mar 2020 : Clinical ResearchThe Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease ...
Med Sci Monit 2020; 26:e923549